THE POWER & SPEED OF
NANOPARTICLE TECHNOLOGY

Novavax creates transformational vaccines that address some of the world’s most pressing infectious diseases

Our approach to science

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.

From respiratory diseases and beyond, our vaccine and adjuvant technology can be applied to address current and emerging global health threats.

SCIENCE & TECHNOLOGY

Matrix-M™ adjuvant technology

Our saponin-based Matrix-M™ adjuvant enhances the immune response and has a dose-sparing effect, both of which are critical to successful vaccine development.

Learn more

SCIENCE & TECHNOLOGY

Recombinant nanoparticle vaccine technology

We are committed to delivering novel products that leverage our innovative proprietary recombinant protein-based nanoparticle technology to prevent a broad range of infectious diseases.

Learn more